MAD1L1 antibody
-
- Target See all MAD1L1 Antibodies
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
-
Reactivity
- Human, Mouse
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This MAD1L1 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Characteristics
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogen
- Recombinant fusion protein of human MAD1L1 (NP_001013859.1).
- Isotype
- IgG
- Top Product
- Discover our top product MAD1L1 Primary Antibody
-
-
- Application Notes
- WB 1:500-1:2000 IHC 1:50-1:200 IF 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
- Alternative Name
- MAD1L1 (MAD1L1 Products)
- Synonyms
- MAD1 antibody, PIG9 antibody, TP53I9 antibody, TXBP181 antibody, AI173502 antibody, AW550425 antibody, Mad1 antibody, zgc:56571 antibody, MAD1-like protein 1 antibody, mitotic arrest deficient 1 like 1 antibody, MAD1 mitotic arrest deficient like 1 antibody, MAD1 mitotic arrest deficient 1-like 1 antibody, deafness, autosomal recessive 19 antibody, MAD1L1 antibody, Mad1l1 antibody, mad1l1 antibody, DFNB19 antibody
- Background
- MAD1L1 is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosome are properly aligned at the metaphase plate. MAD1L1 functions as a homodimer and interacts with MAD2L1. MAD1L1 may play a role in cell cycle control and tumor suppression. Alternative splicing results in multiple transcript variants.
- Molecular Weight
-
Observed_MW: 95 kDa
Calculated_MW: 72 kDa/83 kDa
- Gene ID
- 8379
- UniProt
- Q9Y6D9
- Pathways
- M Phase
-